1. (a) Dyslipidaemia (b) Final MLD P = 0.013 P = 0.004 P = 0.972
Supplemental Fig. 1, Supplemental Digital Content 1
Supplemental Fig. 1. Comparisons of (a) dyslipidaemia, (b) final MLD, (c) distance between ostium of the LAD and proximal edge of the stent, (d) lesion length, (e) LMT-LAD angle (Spider view), (f) LMT-LCX angle (Spider view), (g) LAD-LCX angle (Spider view) and (h) LMT-LAD angle (RAO caudal view) in the no restenosis, in-stent restenosis and in-segment restenosis groups.
(a) Dyslipidaemia
(b) Final MLD
P = 0.013
P = 0.004
P = 0.972
P = 0.530
(mm)
P = 0.007
P = 0.691
3.5
(%)
3.0
100
2.5 80
2.0 60
1.5 40
1.0 20
0.5 No
Restenosis
In-stent
Restenosis
In-segment
Restenosis No
Restenosis
In-stent
Restenosis
In-segment
Restenosis

2. (d) Lesion length P = 0.002 P = 0.590 P = 0.062 (mm) P = 0.411 14 (mm)
(c) Distance between ostium of LAD
and proximal edge of stent
(d) Lesion length
P = 0.002
P = 0.590
P = 0.062
(mm)
P = 0.411 14
(mm)
P = 0.026
P = 0.020 12 30 10 25 8 20 6 15 4 10 2 5 No
Restenosis
In-stent
Restenosis
In-segment
Restenosis No
Restenosis
In-stent
Restenosis
In-segment
Restenosis

3. (e) LMT-LAD angle (Spider view) (f) LMT-LCX angle (Spider view)
(degree)
P<0.001
P = 0.036
P = 0.681
P = 0.688 70
(degree) 60 60 50 50 40 40 30 30 20 20 10 10 No
Restenosis
In-stent
Restenosis
In-segment
Restenosis No
Restenosis
In-stent
Restenosis
In-segment
Restenosis

4. (g) LAD-LCX angle (Spider view) (h) LMT-LAD angle (RAO/CAU view)
(degree)
P<0.001
100
P<0.001
P = 0.403
(degree) 80 40 60 30 40 20 20 10 No
Restenosis
In-stent
Restenosis
In-segment
Restenosis No
Restenosis
In-stent
Restenosis
In-segment
Restenosis